Epstein-Barr Virus gp350-Specific Antibody Titers And Antibody-Dependent Cellular Cytotoxic Effector Function In Different Groups Of Patients: A Study Using Cloned gp350-Expressing Transfected Human T Cell Targets
- 1 December 1994
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 170 (6) , 1439-1447
- https://doi.org/10.1093/infdis/170.6.1439
Abstract
An NK cell activity-resistant human lymphoid T cell line (CEM-NK) expressing the transfected Epstein-Barr virus (EBV) gp350 gene was used in membrane immunofluorescence (MIF) and antibody-dependent cellular cytotoxicity (ADCC) assays to analyze the gp350-specific humoral and ADCC responses in groups ofEBV-seropositive persons. Results show that there is no correlation between gp350-specific ADCC-mediating antibody titers and MIF or EBV neutralizing antibody titers. For example, sera from patients in the acute phase of infectious mononucleosis, while positive by MIF assay or EBV neutralization test, were not reactive in the ADCC assay. Results also show that nasopharyngeal carcinoma (NPC) patients on MIF present high IgG titers against gp350 compared with healthy persons. Anti-gp350 IgA antibodies were detected in all groups tested; however, titers were highest in the NPC group.Keywords
This publication has 0 references indexed in Scilit: